Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies - Textual (Details)

Commitments and Contingencies - Textual (Details)								1 Months Ended				3 Months Ended	12 Months Ended					24 Months Ended
Commitments and Contingencies - Textual (Details)	Feb. 05, 2018 USD ($) $ / shares shares	Dec. 31, 2017 USD ($)	Mar. 23, 2017 USD ($)	Mar. 23, 2017 USD ($) extension	Mar. 23, 2017 USD ($) agreement_renewal	Mar. 23, 2017 USD ($)	Sep. 05, 2014 USD ($) $ / shares shares	Dec. 31, 2017 USD ($) ft² $ / ft²	Jun. 30, 2015 USD ($)	Apr. 30, 2015 USD ($) ft² $ / ft²	Oct. 31, 2014 USD ($)	Feb. 28, 2018 USD ($)	Nov. 30, 2020 USD ($)	Nov. 30, 2018 USD ($)	Nov. 30, 2017 USD ($)	Nov. 30, 2016 USD ($)	Nov. 30, 2013 USD ($)	Nov. 30, 2022 USD ($)	Feb. 22, 2017 USD ($)	Dec. 04, 2015 USD ($)
Leases [Abstract]
Term of contract		3 years						3 years
Dividends and Capital Transactions [Abstract]
Dividends														$ 0	$ 0	$ 0
Exercise of warrant (in shares) \| shares	450,000
Proceeds from exercise of warrant	$ 1,426,500													$ 1,426,500
Number of warrants outstanding \| shares	1,442,744
Mr. Heit
Employment and Severance Agreements [Abstract]
Amount of base salary		$ 300,000									$ 280,000						$ 250,000
Douglas Haas
Employment and Severance Agreements [Abstract]
Unemployment benefits, salary continuation		$ 300,000						$ 300,000											$ 275,000
Period prior to termination date to determine single-sum bonus payment														1 year
Multiplier of average base salary for single-sum payment due upon termination														3
Period prior to termination date to average base salary amounts														3 years
Duration of non-competition restrictions														6 years
Duration of salary continuation during non-competition restrictions														6 months
Alleghany Pharmacal Corporation
Royalty Agreement [Abstract]
Percentage of net sales														2.50%
Annual minimum royalty payable (minimum $250,000)														$ 250,000
Reduced royalty-rate														10.00%
Royalty agreement, option to purchase, amount														$ 500,000
Royalty expense														91,920
Ultimark Products, Inc
Royalty Agreement [Abstract]
Royalty expense														42,798
Agreement term			1 year
Number of agreement renewal options				2	2
Agreement renewal period			1 year
Royalty fee, percent of gross sales						10.00%
Option to purchase, maximum			$ 3,200,000	$ 3,200,000	$ 3,200,000	$ 3,200,000
Accrued royalties														$ 177,791
Capital Preservation Solutions, LLC
Dividends and Capital Transactions [Abstract]
Number of common stock issued upon exercise of warrant (shares) \| shares							1,892,744
Exercise period							5 years
Exercise price of warrants (usd per share) \| $ / shares	$ 3.17						$ 3.17
Exercise of warrant (in shares) \| shares	450,000
Line of Credit
Dividends and Capital Transactions [Abstract]
Face amount of debt																				$ 3,700,000
Line of Credit \| Capital Preservation Solutions, LLC
Dividends and Capital Transactions [Abstract]
Borrowing capacity							$ 5,000,000
Loans Payable \| Capital Preservation Solutions, LLC
Dividends and Capital Transactions [Abstract]
Face amount of debt							$ 1,000,000
Warehouse
Leases [Abstract]
Area of lease office and warehouse space (sqft) \| ft²								1,751		81,000
Annual rental expense												$ 94,992				$ 407,094
Electric charge (usd per square foot) \| $ / ft²								1.75
Monthly rent expense, sublease rentals									$ 36,963
Sublease rentals, term									6 years 10 months 15 days
Sublease rentals, rent annual increase									2.00%
Monthly rent expense									$ 41,931
Annual rent expense for first 18 months								$ 34,145
Annual rent expense for second 18 months								35,020
Annual rent from sub-let								$ 126,038
Office Building
Leases [Abstract]
Area of lease office and warehouse space (sqft) \| ft²										7,414
Annual rental expense										$ 159,401
Electric charge (usd per square foot) \| $ / ft²										1.75
Term of contract										5 years 4 months
Term of free rent										4 months
Forecast \| Alleghany Pharmacal Corporation
Royalty Agreement [Abstract]
Royalty agreement, option to purchase, amount													$ 750,000					$ 1,000,000